Kevin C Sisk, DO | |
812 N 22nd St, Blair, NE 68008-1128 | |
(402) 426-4611 | |
(402) 426-4642 |
Full Name | Kevin C Sisk |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 12 Years |
Location | 812 N 22nd St, Blair, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629330535 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2015015493 (Missouri) | Secondary |
207Q00000X | Family Medicine | 1178 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Community Hospital Mch & Health System | Blair, NE | Hospital |
Good Shepherd Lutheran Home | Blair, NE | Nursing home |
Crowell Memorial Home | Blair, NE | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Community Hospital Corporation | 0749190775 | 19 |
News Archive
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
ImpactRx® announced today that the company has executed a Series E round of financing in the amount of $1.2 million, of which the first tranche of $678,040 was closed on December 23, 2009. ImpactRx is the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest value physicians.
E-cigarettes are a potential smoking cessation aid and they may also be able to lower the risk of nicotine dependency in high-risk groups. The available scientific evidence, however, remains insufficient.
Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
› Verified 6 days ago
Entity Name | Memorial Community Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265408819 PECOS PAC ID: 0749190775 Enrollment ID: O20040202001065 |
News Archive
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
ImpactRx® announced today that the company has executed a Series E round of financing in the amount of $1.2 million, of which the first tranche of $678,040 was closed on December 23, 2009. ImpactRx is the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest value physicians.
E-cigarettes are a potential smoking cessation aid and they may also be able to lower the risk of nicotine dependency in high-risk groups. The available scientific evidence, however, remains insufficient.
Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Kevin C Sisk, DO 810 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-2182 | Kevin C Sisk, DO 812 N 22nd St, Blair, NE 68008-1128 Ph: (402) 426-4611 |
News Archive
A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.
ImpactRx® announced today that the company has executed a Series E round of financing in the amount of $1.2 million, of which the first tranche of $678,040 was closed on December 23, 2009. ImpactRx is the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest value physicians.
E-cigarettes are a potential smoking cessation aid and they may also be able to lower the risk of nicotine dependency in high-risk groups. The available scientific evidence, however, remains insufficient.
Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
› Verified 6 days ago
Sean C. Erickson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Johnnie K Simonson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 | |
Santosh Kumar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-2182 | |
Amber Lynn Beckenhauer, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 407 S 19th St, Blair, NE 68008 Phone: 402-552-3222 Fax: 402-552-2172 | |
Dr. Mark Edward Shirley, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-2182 Fax: 402-426-1190 | |
Amanda Duxbury, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 812 N 22nd St, Blair, NE 68008 Phone: 402-426-4611 Fax: 402-426-4642 |